These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23598051)

  • 21. Dental units as infection sources of Pseudomonas aeruginosa.
    Barben J; Schmid J
    Eur Respir J; 2008 Oct; 32(4):1122-3. PubMed ID: 18827162
    [No Abstract]   [Full Text] [Related]  

  • 22. Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides--players in the predicament of cystic fibrosis patients.
    Pier GB
    Trends Microbiol; 2000 Jun; 8(6):247-50; discussion 250-1. PubMed ID: 10838574
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways.
    Gabrielaite M; Johansen HK; Molin S; Nielsen FC; Marvig RL
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudomonal infection in cystic fibrosis: the battle continues.
    Elkin S; Geddes D
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):609-18. PubMed ID: 15482158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by
    Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V
    Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis.
    Ashish A; Paterson S; Mowat E; Fothergill JL; Walshaw MJ; Winstanley C
    J Cyst Fibros; 2013 Dec; 12(6):790-3. PubMed ID: 23642644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.
    Tyrrell J; Callaghan M
    Microbiology (Reading); 2016 Feb; 162(2):191-205. PubMed ID: 26643057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there value in susceptibility testing of Pseudomonas aeruginosa causing chronic infection in patients with cystic fibrosis?
    Gilligan PH
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):711-5. PubMed ID: 17140346
    [No Abstract]   [Full Text] [Related]  

  • 31. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections.
    Wilder CN; Allada G; Schuster M
    Infect Immun; 2009 Dec; 77(12):5631-9. PubMed ID: 19805523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
    Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.
    Ernst RK; Moskowitz SM; Emerson JC; Kraig GM; Adams KN; Harvey MD; Ramsey B; Speert DP; Burns JL; Miller SI
    J Infect Dis; 2007 Oct; 196(7):1088-92. PubMed ID: 17763333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
    Tingpej P; Smith L; Rose B; Zhu H; Conibear T; Al Nassafi K; Manos J; Elkins M; Bye P; Willcox M; Bell S; Wainwright C; Harbour C
    J Clin Microbiol; 2007 Jun; 45(6):1697-704. PubMed ID: 17392437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
    Cigana C; Curcurù L; Leone MR; Ieranò T; Lorè NI; Bianconi I; Silipo A; Cozzolino F; Lanzetta R; Molinaro A; Bernardini ML; Bragonzi A
    PLoS One; 2009 Dec; 4(12):e8439. PubMed ID: 20037649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Parkins MD; Elborn JS
    Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.
    Weiser R; Rye PD; Mahenthiralingam E
    J Microbiol Methods; 2021 Feb; 181():106133. PubMed ID: 33421446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.